Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fludarabine
Ovarian Cancer
Zelluna Immunotherapy AS
P3
BBB
(74)
Fludarabine
Prolymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P3
BBB
(74)
Fludarabine
Lymphoblastic Lymphoma
Ohio State University Comprehensive Cancer Center
P3
BBB
(74)
Fludarabine
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Nathan Denlinger
P3
BBB
(74)
Fludarabine
Myelodysplastic Syndrome With Single Lineage Dysplasia
Fred Hutchinson Cancer Center
P3
BBB
(74)
Fludarabine
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P3
BBB
(74)
Fludarabine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P3
BBB
(74)
Fludarabine
Splenic Marginal Zone Lymphoma
UNC Lineberger Comprehensive Cancer Center
P3
BBB
(74)
Fludarabine
Disease Related To Transplantation
M.D. Anderson Cancer Center
P3
BBB
(74)
Fludeoxyglucose
Non-Small Cell Lung Carcinoma
Alliance for Clinical Trials in Oncology
P3
BBB
(74)
Fludeoxyglucose
Plasma Cell Myeloma
National Cancer Institute (NCI)
P3
BBB
(74)
Fluorine (18F) Psma 1007
Prostate Cancer
Novartis Pharmaceuticals
P3
BBB
(74)
Fluorouracilum
Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BBB
(74)
Fluorouracilum
Cholangiocarcinoma
Jonsson Comprehensive Cancer Center
P3
BBB
(74)
Fluorouracilum
Colorectal Adenocarcinoma
Centre Hospitalier Universitaire Dijon
P3
BBB
(74)
Fluorouracilum
Peritoneum Cancer
City of Hope Medical Center
P3
BBB
(74)
Fluorouracilum
Non-Small Cell Lung Carcinoma
Fudan University
P3
BBB
(74)
Fluorouracilum
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P3
BBB
(74)
Fluorouracilum
Neoplasm
Mirati Therapeutics Inc.
P3
BBB
(74)
Flutemetamol
Alzheimer Disease
Akiva Mintz
P3
BBB
(74)
Gemtuzumab Ozogamicin
Acute Myeloid Leukemia
German Cancer Research Center
P3
BBB
(74)
Immunoglobulin G1, Anti-(Human 5'-Nucleotidase) (Human Monoclonal Medi9447 Heavy Chain), Disulfide With Human Monoclonal Medi9447 .Lambda.-Chain, Dimer
Non-Small Cell Lung Carcinoma
Montefiore Medical Center
P3
BBB
(74)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
P3
BBB
(74)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Non-Small Cell Lung Carcinoma
University of Chicago
P3
BBB
(74)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Skin Squamous Cell Carcinoma
Regeneron Pharmaceuticals
P3
BBB
(74)
Showing 1926 to 1950 of 42,289 assets
Previous
Page 78 of 1692
Next